OCUL- Ocular Therapeutix, Inc.

Name: Ocular Therapeutix, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ocular Therapeutix, Inc. (OCUL) has 9 insiders with recent SEC Form 4 filings, including 2 buys and 8 sells. OCUL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Dugel Pravin	394.7K	$3.94M	-
Other	Notman Donald	389.3K	$3.88M	-
Other	Nayak Sanjay	330.7K	$3.30M	-
Other	Waheed Nadia	326.3K	$3.25M	-
Other	Heier Jeffrey S.	323.4K	$3.22M	-

Activity

Buys and sells only

Transactions

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 5, 2024	Strassburger Philip C.	General Counsel	Sell	6,029	$4.86	$29,300.94	-3.6%	+17.2%	+58.0%
Feb 5, 2024	Mattessich Antony C.47	President And CEO	Sell	19,642	$4.86	$95,460.12	-3.2%	+17.2%	+58.0%
Jan 31, 2024	Notman Donald	Chief Financial Officer	Sell	6,433	$4.95	$31,843.35	-4.4%	-2.5%	+60.1%
Jan 31, 2024	Ozden Rabia Gurses	Chief Medical Officer	Sell	7,764	$4.95	$38,431.80	-7.7%	-2.5%	+60.1%
Jan 31, 2024	Strassburger Philip C.	General Counsel	Sell	6,831	$4.95	$33,813.45	-5.9%	-2.5%	+60.1%
Jan 31, 2024	White Christopher G	Chief Business Officer	Sell	5,147	$4.95	$25,477.65	-5.4%	-2.5%	+60.1%
Jan 31, 2024	Mattessich Antony C.47	President And CEO	Sell	18,338	$4.95	$90,773.10	-4.1%	-2.5%	+60.1%
Dec 14, 2023	Summer Road LLC47	-	Buy	1,538,461	$3.25	$4,999,998.25	+25.1%	+153.0%	+129.3%
Aug 30, 2023	Mattessich Antony C.47	President And CEO	Buy	6,500	$3.81	$24,765.00	New	-40.5%	+122.3%
Jul 7, 2023	Ozden Rabia Gurses	Chief Medical Officer	Sell	832	$4.93	$4,101.76	-0.8%	-39.1%	+36.4%

← PrevPage 5Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC